425 related articles for article (PubMed ID: 25535823)
1. Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease.
Farid M; Agrawal A; Fremgen D; Tao J; Chuyi H; Nesburn AB; BenMohamed L
Ocul Immunol Inflamm; 2016 Jun; 24(3):327-47. PubMed ID: 25535823
[TBL] [Abstract][Full Text] [Related]
2. Mucosal tolerance disruption favors disease progression in an extraorbital lacrimal gland excision model of murine dry eye.
Guzmán M; Keitelman I; Sabbione F; Trevani AS; Giordano MN; Galletti JG
Exp Eye Res; 2016 Oct; 151():19-22. PubMed ID: 27443502
[TBL] [Abstract][Full Text] [Related]
3. Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis.
Chen Y; Chauhan SK; Lee HS; Stevenson W; Schaumburg CS; Sadrai Z; Saban DR; Kodati S; Stern ME; Dana R
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2457-64. PubMed ID: 23482465
[TBL] [Abstract][Full Text] [Related]
4. Lacrimal gland-derived IL-22 regulates IL-17-mediated ocular mucosal inflammation.
Ji YW; Mittal SK; Hwang HS; Chang EJ; Lee JH; Seo Y; Yeo A; Noh H; Lee HS; Chauhan SK; Lee HK
Mucosal Immunol; 2017 Sep; 10(5):1202-1210. PubMed ID: 28051088
[TBL] [Abstract][Full Text] [Related]
5. Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease.
Gao Y; Min K; Zhang Y; Su J; Greenwood M; Gronert K
J Immunol; 2015 Oct; 195(7):3086-99. PubMed ID: 26324767
[TBL] [Abstract][Full Text] [Related]
6. Single-cell landscape reveals the epithelial cell-centric pro-inflammatory immune microenvironment in dry eye development.
Liu Z; Xie H; Li L; Jiang D; Qian Y; Zhu X; Dai M; Li Y; Wei R; Luo Z; Xu W; Zheng Q; Shen J; Zhou M; Zeng W; Chen W
Mucosal Immunol; 2024 Jun; 17(3):491-507. PubMed ID: 38007004
[TBL] [Abstract][Full Text] [Related]
7. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
[TBL] [Abstract][Full Text] [Related]
8. Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease.
Guzmán M; Keitelman I; Sabbione F; Trevani AS; Giordano MN; Galletti JG
Clin Exp Immunol; 2016 May; 184(2):248-56. PubMed ID: 26690299
[TBL] [Abstract][Full Text] [Related]
9. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
Sheppard J; Shen Lee B; Periman LM
Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
[TBL] [Abstract][Full Text] [Related]
10. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
Periman LM; Perez VL; Saban DR; Lin MC; Neri P
J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
[TBL] [Abstract][Full Text] [Related]
11. Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease.
Ratay ML; Glowacki AJ; Balmert SC; Acharya AP; Polat J; Andrews LP; Fedorchak MV; Schuman JS; Vignali DAA; Little SR
J Control Release; 2017 Jul; 258():208-217. PubMed ID: 28501670
[TBL] [Abstract][Full Text] [Related]
12. Cluster Analysis of Dry Eye Disease Models Based on Immune Cell Parameters - New Insight Into Therapeutic Perspective.
Lio CT; Dhanda SK; Bose T
Front Immunol; 2020; 11():1930. PubMed ID: 33133058
[TBL] [Abstract][Full Text] [Related]
13. Chronic dry eye disease is principally mediated by effector memory Th17 cells.
Chen Y; Chauhan SK; Lee HS; Saban DR; Dana R
Mucosal Immunol; 2014 Jan; 7(1):38-45. PubMed ID: 23571503
[TBL] [Abstract][Full Text] [Related]
14. Ocular surface disease and dacryoadenitis in aging C57BL/6 mice.
McClellan AJ; Volpe EA; Zhang X; Darlington GJ; Li DQ; Pflugfelder SC; de Paiva CS
Am J Pathol; 2014 Mar; 184(3):631-43. PubMed ID: 24389165
[TBL] [Abstract][Full Text] [Related]
15. FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue.
Xiao W; Xu GT; Zhang J; Zhang J; Zhang Y; Ye W
Exp Eye Res; 2015 Sep; 138():145-52. PubMed ID: 26187517
[TBL] [Abstract][Full Text] [Related]
16. [A new approach for better comprehension of diseases of the ocular surface].
Baudouin C
J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the inflammatory component in chronic dry eye disease by the eye-associated lymphoid tissue (EALT).
Knop N; Knop E
Dev Ophthalmol; 2010; 45():23-39. PubMed ID: 20502024
[TBL] [Abstract][Full Text] [Related]
18. Tear biomarkers in dry eye disease: Progress in the last decade.
Kumar NR; Praveen M; Narasimhan R; Khamar P; D'Souza S; Sinha-Roy A; Sethu S; Shetty R; Ghosh A
Indian J Ophthalmol; 2023 Apr; 71(4):1190-1202. PubMed ID: 37026250
[TBL] [Abstract][Full Text] [Related]
19. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.
Barabino S; Chen Y; Chauhan S; Dana R
Prog Retin Eye Res; 2012 May; 31(3):271-85. PubMed ID: 22426080
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
